Additional Details
- 
                    Nucleoside Therapy in Patients With Telomere Biology DisordersBoston Childrens HospitalBoston MA. 02115View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionAdventHealth OrlandoOrlando FL. 32803View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionUniversity of Alabama at BirminghamBirmingham AL. 35205View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionNational Jewish HealthDenver CO. 80206View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionUniversity of MinnesotaMinneapolis MN. 55455View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionUniversity of KentuckyLexington KY. 40536View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionUniversity of Michigan - Michigan MedicineAnn Arbor MI. 48109-5360View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionDignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic InstitutePhoenix AZ. 85013View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionCHI Health Creighton University Medical Center - Bergan MercyOmaha NE. 68124View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionUniversity of Illinois HealthChicago IL. 60612View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionBaylor University Medical CenterDallas TX. 75246View Details
- 
                    Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionIndiana University Health Methodist HospitalIndianapolis IN. 46202View Details
- 
                    Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary FibrosisSnyder Building 480 Ray C. Hunt DriveCharlottesville VA. 22908View Details
- 
                    Inspiratory Work of Breathing Before and After ExtubationToronto General Hospital, University Health NetworkToronto ON. M5G2C4View Details
- 
                    Reimagining Interventions for Support and Education in Hypersensitivity PneumonitisWeill Cornell MedicineNew York NY. 10065View Details
- 
                    WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)WISPer site in Trois-Rivières, QuebecTrois-Rivières QC. G8T 7A1View Details
- 
                    WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)WISPer site in Kansas City, KSKansas City KS. 66160View Details
- 
                    WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)WISPer site in Dallas, TXDallas TX. 75204View Details
- 
                    WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)WISPer site in Oklahoma City, OKOklahoma City OK. 73104View Details
